URGN - UroGen Pharma Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

URGN is currently covered by 4 analysts with an average price target of $47.13. This is a potential upside of $10.3 (27.97%) from yesterday's end of day stock price of $36.83.

UroGen Pharma Ltd's activity chart (see below) currently has 151 price targets and 126 ratings on display. The stock rating distribution of URGN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.25% with an average time for these price targets to be met of 572.24 days.

Highest price target for URGN is $75, Lowest price target is $33, average price target is $47.13.

Most recent stock forecast was given by BRADLEY CANINO from GUGGENHEIM on 06-Aug-2026. First documented stock forecast 30-May-2017.

Currently out of the existing stock ratings of URGN, 17 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Jul-2026

$58

$21.17 (57.48%)

$42

2 months 7 days ago
(06-Aug-2026)

1/2 (50%)

$12.4 (27.19%)

3

Buy Since 08-Jul-2025

$75

$38.17 (103.64%)

$45

2 months 7 days ago
(06-Aug-2026)

14/34 (41.18%)

$29.4 (64.47%)

694

Buy Since 28-Feb-2019

$50

$13.17 (35.76%)

$40

2 months 27 days ago
(16-Jul-2026)

20/23 (86.96%)

$10 (25.00%)

1021

Buy Since 02-Jan-2018

$43

$8.46 (24.49%)

$53.5

5 months 1 days ago
(11-May-2026)

2/4 (50%)

$11.67 (37.25%)

42

Buy Since 14-Oct-2024

$33

$-1.54 (-4.46%)

$33

6 months 11 days ago
(31-Mar-2026)

22/22 (100%)

$15.02 (83.54%)

217

Show more analysts

Please expand the browser size to see the chart

What is URGN (UroGen Pharma Ltd) average time for price targets to be met?

On average it took 572 days for the stock forecasts to be reached, with an average price target met ratio of 69.25%.

Which analyst most recently updated their price target on URGN (UroGen Pharma Ltd)?

Bradley Canino

Which analyst has the most public recommendations on URGN (UroGen Pharma Ltd)?

Bradley Canino works at GUGGENHEIM and has 24 price targets and 17 ratings on URGN

Which analyst is the currently most bullish on URGN (UroGen Pharma Ltd)?

Raghuram Selvaraju with the highest potential upside of $38.17

Which analyst is the currently most reserved on URGN (UroGen Pharma Ltd)?

Chris Howerton with the lowest potential downside of -$26.83
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?